French Cohort Study Maps Perinatal Risks for Neurodevelopmental Disorders

The Perinatal Roots of Neurodevelopmental Diversity

Neurodevelopmental disorders represent a significant global health burden, with the majority of symptoms manifesting before age five [1]. While high heritability is well established, environmental influences during the critical prenatal and perinatal windows are increasingly recognized as vital modulators of brain maturation [2, 3]. Clinical management is often complicated by the fact that these conditions rarely exist in isolation, frequently presenting as a complex mosaic of overlapping cognitive and behavioral challenges [4]. Identifying modifiable risk factors, such as maternal metabolic health or specific birth complications, remains a priority for improving long term pediatric outcomes [5, 6]. A massive nationwide cohort study (a longitudinal study following a large, representative population over time) now clarifies how early life exposures specifically shape the risk for different diagnostic trajectories.

A Nationwide Analysis of 7.4 Million Births

The researchers utilized the EPI-MERES Register, a comprehensive database derived from the French National Health Data System, to conduct this nationwide cohort study. The analysis included 7.46 million children born in France between 2010 and 2018, representing a complete national birth cohort. This extensive dataset allowed the authors to track clinical outcomes with high statistical precision across a diverse population. The children were followed until September 2024, providing a median follow-up period of 10.3 years, which is a sufficient duration to capture neurodevelopmental diagnoses that often emerge during the school age years. The study specifically investigated the incidence and risk profiles of five major neurodevelopmental disorders: communication disorders, learning disorders, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and intellectual disability. Within this cohort, 511,619 children (6.8%) received a diagnosis of at least one neurodevelopmental disorder during the follow-up period. By analyzing this large scale population, the researchers were able to account for the frequent co-occurrence of these conditions, providing a detailed map of how specific prenatal and perinatal exposures contribute to distinct diagnostic trajectories.

The Clinical Reality of Diagnostic Co-occurrence

In clinical practice, neurodevelopmental conditions rarely present as isolated entities, a reality that often complicates diagnostic clarity and long term management. The study findings emphasize that co-occurrence was frequent across the cohort, particularly among children with more pervasive developmental challenges. Specifically, the researchers found that 54.5% of children with intellectual disability also met the criteria for at least one other neurodevelopmental disorder. This high rate of overlap was also observed in children with autism spectrum disorder, where 52.2% of the population presented with comorbid conditions. Even among children with ADHD, a condition often viewed through a more singular lens, 34.9% of cases involved at least one additional neurodevelopmental diagnosis. To ensure that the identified risk factors were truly associated with specific conditions rather than general neurodevelopmental impairment, the researchers utilized statistical models that accounted for co-occurring neurodevelopmental disorders. This methodological choice is critical for clinicians because it helps isolate which prenatal or perinatal exposures are uniquely linked to a specific diagnostic profile. By adjusting for these overlaps, the study provides a clearer map of etiological pathways, suggesting that while some risk factors are shared across the spectrum, others are highly specific to certain disorders. For the practicing physician, these data reinforce the necessity of comprehensive, multi-disciplinary screening, as more than half of patients with intellectual disability or autism spectrum disorder will likely require support for multiple, overlapping developmental needs.

Universal Risk Factors Across the Neurodevelopmental Spectrum

The researchers investigated a comprehensive set of prenatal and perinatal risk factors to determine their influence on the development of communication disorders, learning disorders, ADHD, autism spectrum disorder, and intellectual disability. These factors included gestational age, small for gestational age (SGA), neonatal hypoxia, and congenital malformations. By analyzing the 7.46 million children in the cohort, the study identified several core variables that increased the likelihood of a diagnosis regardless of the specific type of neurodevelopmental impairment. Specifically, male sex, prematurity, and being small for gestational age (SGA), which refers to a birth weight falling below the 10th percentile for a child's gestational age, were consistently associated with elevated risk across all five neurodevelopmental disorders. In addition to birth timing and weight, structural and environmental influences during gestation played a significant role in long term outcomes. The presence of congenital malformations was identified as a consistent risk factor, showing a stable association with increased diagnostic rates across the entire neurodevelopmental spectrum. The study also quantified the impact of prenatal substance exposure, finding that maternal alcohol or tobacco exposure was consistently associated with elevated risk across all five neurodevelopmental disorders. For the practicing physician, these data suggest that these specific perinatal markers do not point to a single condition but rather indicate a generalized vulnerability that necessitates broad developmental monitoring from infancy through adolescence.

Disorder-Specific Profiles and Environmental Modulators

While certain perinatal factors exert a broad influence, the study identified distinct risk profiles that differentiate specific neurodevelopmental outcomes. The researchers found that congenital malformations, extreme prematurity, and neonatal hypoxia (a clinical state of oxygen deprivation at birth) showed the strongest associations with intellectual disability. Parental age also emerged as a significant but divergent modulator of risk. Specifically, advanced parental age was linked to an increased likelihood of autism spectrum disorder and intellectual disability, whereas younger parental age was associated with ADHD. These findings suggest that the biological or social mechanisms contributing to these conditions may vary based on the timing of parenthood. The analysis further delineated the impact of maternal substance exposure and socioeconomic factors on long term development. Maternal alcohol exposure was particularly associated with ADHD, autism spectrum disorder, and intellectual disability, while maternal tobacco exposure was linked to ADHD and learning disorders. The role of socioeconomic disadvantage, a composite measure of limited financial and social resources, proved complex. While socioeconomic disadvantage increased the risk for autism spectrum disorder, intellectual disability, and communication disorders, it was inversely associated with ADHD and learning disorders. This inverse relationship may not indicate a protective effect of lower socioeconomic status but rather could reflect disparities in healthcare access or diagnostic patterns within different social strata, highlighting the need for clinicians to consider social determinants of health when evaluating developmental delays.

References

1. Solmi M, Raduà J, Olivola M, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Molecular Psychiatry. 2021. doi:10.1038/s41380-021-01161-7

2. Carlsson T, Molander F, Taylor MJ, Jönsson U, Bölte S. Early environmental risk factors for neurodevelopmental disorders – a systematic review of twin and sibling studies. Development and Psychopathology. 2020. doi:10.1017/s0954579420000620

3. Modabbernia A, Velthorst E, Reichenberg A. Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analyses. Molecular Autism. 2017. doi:10.1186/s13229-017-0121-4

4. Mehari A, Zeleke S. Prevalence, trends in, and factors associated with neurodevelopmental disorders (NDDs) in low- and low-middle income countries (LLMICs): A systematic review and meta-analysis.. Research in Developmental Disabilities. 2025. doi:10.1016/j.ridd.2025.105186

5. Han VX, Patel S, Jones H, et al. Maternal acute and chronic inflammation in pregnancy is associated with common neurodevelopmental disorders: a systematic review. Translational Psychiatry. 2021. doi:10.1038/s41398-021-01198-w

6. Oliveira MEGBD, Saia ALT, Casarin JV, et al. IMPACT OF ECLAMPSIA AND PREECLAMPSIA ON CHILD DEVELOPMENT: A SYSTEMATIC REVIEW. Lumen et Virtus. 2026. doi:10.56238/levv17n56-015